ATE397624T1 - Cystine-knot fold protein - Google Patents

Cystine-knot fold protein

Info

Publication number
ATE397624T1
ATE397624T1 AT02788225T AT02788225T ATE397624T1 AT E397624 T1 ATE397624 T1 AT E397624T1 AT 02788225 T AT02788225 T AT 02788225T AT 02788225 T AT02788225 T AT 02788225T AT E397624 T1 ATE397624 T1 AT E397624T1
Authority
AT
Austria
Prior art keywords
protein
cystine knot
knot fold
fold protein
cystine
Prior art date
Application number
AT02788225T
Other languages
German (de)
English (en)
Inventor
Mark Douglas Davies
Christopher Benjamin Phelps
Richard Joseph Fagan
Christine Power
Melanie Yorke-Smith
Mark Ibberson
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Application granted granted Critical
Publication of ATE397624T1 publication Critical patent/ATE397624T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
AT02788225T 2001-12-21 2002-12-20 Cystine-knot fold protein ATE397624T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130738.8A GB0130738D0 (en) 2001-12-21 2001-12-21 Protein

Publications (1)

Publication Number Publication Date
ATE397624T1 true ATE397624T1 (de) 2008-06-15

Family

ID=9928236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02788225T ATE397624T1 (de) 2001-12-21 2002-12-20 Cystine-knot fold protein

Country Status (15)

Country Link
US (1) US7619065B2 (enExample)
EP (1) EP1463754B1 (enExample)
JP (1) JP2005528336A (enExample)
KR (1) KR20040089093A (enExample)
CN (1) CN1620466A (enExample)
AT (1) ATE397624T1 (enExample)
AU (1) AU2002353207B2 (enExample)
CA (1) CA2470781A1 (enExample)
DE (1) DE60227002D1 (enExample)
EA (1) EA007611B1 (enExample)
ES (1) ES2306802T3 (enExample)
GB (1) GB0130738D0 (enExample)
IL (2) IL162592A0 (enExample)
MX (1) MXPA04006062A (enExample)
WO (1) WO2003055911A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130738D0 (en) 2001-12-21 2002-02-06 Serono Internat S A Protein
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
EP1755648A2 (en) 2004-05-27 2007-02-28 Acceleron Pharma Inc. Cerberus/coco derivatives and uses thereof
US9045553B2 (en) * 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
EP2010206A1 (en) * 2006-01-12 2009-01-07 Ares Trading S.A. Cystine-knot fold cytokine
JP2010512326A (ja) 2006-12-08 2010-04-22 アクセルロン ファーマ， インコーポレイテッド Ｃｅｒｂｅｒｕｓ、Ｃｏｃｏおよびこれらの誘導体の使用
US8642339B2 (en) 2009-02-03 2014-02-04 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
TWI799366B (zh) * 2015-09-15 2023-04-21 美商建南德克公司 胱胺酸結骨架平臺
US10961305B2 (en) 2016-12-21 2021-03-30 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta
GB201721615D0 (en) 2017-12-21 2018-02-07 Koninklijke Nederlandse Akademie Van Wetenschappen Immune cell organoid co-cultures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130738D0 (en) 2001-12-21 2002-02-06 Serono Internat S A Protein
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA

Also Published As

Publication number Publication date
EP1463754A2 (en) 2004-10-06
DE60227002D1 (en) 2008-07-17
JP2005528336A (ja) 2005-09-22
US7619065B2 (en) 2009-11-17
KR20040089093A (ko) 2004-10-20
IL162592A (en) 2009-12-24
EA007611B1 (ru) 2006-12-29
EP1463754B1 (en) 2008-06-04
WO2003055911A8 (en) 2004-02-05
CA2470781A1 (en) 2003-07-10
US20050186663A1 (en) 2005-08-25
ES2306802T3 (es) 2008-11-16
CN1620466A (zh) 2005-05-25
EA200400813A1 (ru) 2005-04-28
AU2002353207B2 (en) 2009-01-08
IL162592A0 (en) 2005-11-20
WO2003055911A2 (en) 2003-07-10
AU2002353207A1 (en) 2003-07-15
GB0130738D0 (en) 2002-02-06
WO2003055911A3 (en) 2003-08-28
MXPA04006062A (es) 2004-09-27

Similar Documents

Publication Publication Date Title
DE60227002D1 (en) Cystine-knot fold protein
WO2003055912A3 (en) Secreted proteins
DE602004025509D1 (de) Virales latentphasen-interleukin-10-(vii-10) und verwendungen davon
WO2004096856A3 (en) Secreted protein family
ATE482976T1 (de) Defensinproteine
ATE526400T1 (de) Metalloproteaseproteine
MXPA05009954A (es) Familia de proteinas secretadas.
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
WO2004101618A3 (en) Progestin-yol002c-cgi-45 receptor-related proteins
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2003054178A3 (en) Metalloprotease proteins
EA200501843A1 (ru) Tnf-подобный секретируемый белок
WO2004000882A3 (en) Proteins
WO2002029062A3 (en) Cytokine proteins
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2003100061A3 (en) Three finger toxin fold proteins
WO2002062976A3 (en) Serine proteases
WO2002062845A3 (en) Adhesion molecules
WO2002044382A8 (en) Cytokine-like proteins
WO2004026905A3 (en) Transporter/channel proteins
WO2005080425A3 (en) Leucine rich repeat containing protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties